(Q33283794)

25 July 2017

High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation (English)

1 reference

high-throughput screening

25 July 2017

0 references

Carlo Ballatore

2

0 references

John Q. Trojanowski

series ordinal

4

object named as

John Q Trojanowski

1 reference

25 July 2017

Alex Crowe

1

1 reference

25 July 2017

Edward Hyde

series ordinal

3

1 reference

25 July 2017

Virginia M-Y Lee

series ordinal

5

1 reference

25 July 2017

language of work or name

English

0 references

publication date

19 March 2007

1 reference

Biochemical and Biophysical Research Communications

25 July 2017

1 reference

25 July 2017

358

1 reference

25 July 2017

1

1 reference

25 July 2017

1-6

1 reference

Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications

25 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646256

Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646256

Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646256

Protein aggregation and neurodegenerative disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646256

Small-molecule inhibitors of protein-protein interactions: progressing towards the dream

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646256

Identification of a novel class of orally active pyrimido[5,4-3][1,2,4]triazine-5,7-diamine-based hypoglycemic agents with protein tyrosine phosphatase inhibitory activity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646256

A specific mechanism of nonspecific inhibition

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646256

A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646256

Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646256

Microtubule-stabilising drugs for therapy of Alzheimer's disease and other neurodegenerative disorders with axonal transport impairments.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646256

Ligand-dependent inhibition and reversal of tau filament formation

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646256

10.1016/J.BBRC.2007.03.056

31 October 2018

Identifiers

DOI

1 reference

25 July 2017

1 reference

25 July 2017

1 reference